Female infertility and endocrinological diseases

Year 2013, Volume: 40 Issue: 4, 700 - 703, 01.12.2013

Hakan İbrahim Boyar

https://doi.org/10.5798/diclemedj.0921.2013.04.0363

Cited By: 4

Abstract

In this review endocrinologic diseases are briefly discussed regarding their interrelated aspects with infertility. Many endocrinologic diseases are underestimated during infertility treatment. As careful differential diagnosis performed, this problem can be easily overcome.

Keywords

endocrine diseases, infertility, diagnosis, treatment

Kadın infertilitesi ve endokrinolojik hastalıklar

Abstract

Bu derlemede endokrinolojik hastalıkların infertiliteye bakan yönü kısaca tartışılmıştır. Birçok endokrinolojik hastalık infertilite tedavisi esnasında gözden kaçırılmaktadır. Dikkatli ayırıcı tanı yapılması durumunda ise bu problemler kolayca aşılabilir.

Keywords

Endokrin hastalıklar, infertilite, tanı, tedavi

References

• Vayena E, Rowe P, Griffin P. Current Practices and Contro- versies in Assisted Reprudiction. Report of a meeting on Medical, Ethical and Social Aspets of Assisted Reprodic- tion held at WHO Headquarters. 17-21 September 2001, Geneva - Switzerland, 2002.
• Mosher WD, Pratt WF. Fecundity and infertility in the United States: incidence and trends. Fertil Steril 1991;56:192.
• Gnoth C, Godehardt D, Godehardt E, Frank-Herrmann P, Freundl G. Time to pregnancy: results of the German pro- spective study and impact on the management of infertility. Hum Reprod 2003;18:1959-1966.
• Thonneau P, Marchand S, Tallec A, et al. Incidence and main causes of infertility in a resident population of three French regions. Hum Reprod 1991;6:811-816.
• Gordon CM. Functional hypothalamic amenorrhea. New Engl J Med 2010;263:365-371.
• Caronia LM, Martin C, Welt CK, et al. A genetic basis for functional hypothalamic amenorrhea. New Engl J Med 2011;364:215-225.
• Talbert LM, Raj MHG, Hammond MG, Greer T. Endocrine and immunologic studies in a patient with resistant ovary syndrome. Fertil Steril 1984;42:741.
• Alper MM, Garner PR. Premature ovarian failure: its relation- ship to autoimmune disease. Obstet Gynecol 1985;66:27.
• Robinson ACR, Dockeray CJ, Cullen MJ, Sweeney EC. Hypergonadotrophic hypogonadism in classical galacto- saemia: evidence for defective oogenesis: case report. Br J Obstet Gynecol 1984;91:199.
• Melmed S, Casanueva F, Hoffman A, et al. Diagnosis and treatment of hyperprolactinemia: an endocrine soci- ety clinical practice guideline. J Clin Endocrinol Metab 2011;96:273-288.
• Barlier A, Jaquet P. Quinagolide-a valuable treatment option for hyperprolactinaemia. Eur J Endocrinol 2006;154:187- 195.
• Iannaccone A, Gabrilove JL, Sohval AR, et al. The ovaries in Cushing’s syndrome. New Engl J Med 1959;261:775- 780.
• Ga Kaltsas, Korbonits M, Isidori AM, et al. How common are polycystic ovaries and the polycystic ovarian syndrome in women with Cushing’s syndrome? Clin Endocrinol (Ox- ford) 2000;53:493-500.
• Lindsay RS, Toft AD. Hypothyroidism. Lancet 1997;349:413.
• Bohnet HG, Fiedler K, Leidenberger FA. Subclinical hypo- thyroidism and infertility. Lancet 1981;2:1278.
• Joshi JV, Bhandarkar SD, Chadha M, et al. Menstrual ir- regularities and lactation failure may precede thyroid dys- function or goitre. J Postgrad Med 1993;39:137-141.
• Speiser PW, Azziz R, Baskin LS, et al. Congenital adrenal hyperplasia duet to Steroid 21-Hydroxylase deficiëntie: an endocrine society clinical practice guideline. J Clin Endo- crinol Metab 2010;95:4133-4160.
• Hagenfeldt K, Janson PO, Holmdahl G, et al. Fertility and pregnancy outcome in women with congenital adrenal hy- perplasia due to 21-hydroxylase deficiency. Hum Reprod 2008;23:1607-1613.
• Merke DP. Approach to the Adult with congenital adrenal hyperplasia due to 21-Hydroxylase deficiency. J Clin Endo- crinol Metab 2008;93:653-660.
• Dunaif A, Graf M, Mandeli J, et al. Characterization of groups of hyperandrogenic women with acanthosis nigri- cans, impaired glucose tolerance and/or hyperinsulinemia. J Clin Endocrinol Metab 1987;65:499.
• Schwartz MW, Seeley RJ. Neuroendocrine responses to starvation and weight loss. New Engl J Med 1997;336:1802.
• Revised 2003 consensus on diagnostic criteria and long- term health risks related to polycystic ovary syndrome (PKOS). Rotterdam ESHRE/ASRM-Sponsored PKOS consensus workshop group. Hum Reprod 2004;19:41-47.
• March WA, Moore VM, Willson KJ, et al. The prevalence of polycystic ovary syndrome in a community sample as- sessed under contrasting diagnostic criteria. Hum Reprod 2010;25:544-551.
• Legro RS. Pregnancy considerations in women with poly- cystic ovary syndrome. Clin Obstet Gynecol 2007;50:295- 304.
• Pasquali R, Casimirri F, Balestra V, Flamia R, Melchionda N, Fabbri R, Barbara L. The relative contribution of andro- gens and insulin in determining abdominal fat distribution in premenopausal women. J Endocrinol Invest 1991;14:839.
• Peiris AN, Sothmann MS, Aiman EJ, Kissebah AH. The re- lationship of insulin to sex hormone binding globulin: role of adiposity. Fertil Steril 1989;52:69.
• Legro RS, Barnhart HX, et al. Clomiphene, metformin, or both for infertility in the polycystic ovary syndrome. New Engl J Med 2007;356:551.
• Moll E, Bossuyt PMM, et al. Effect of clomifene citrate plus metformin and clomifene citrate plus placebo on induction of ovulation in women with newly diagnosed polycystic ovary syndrome: randomised double blind clinical trial. British Med J 2006;332:1485-1489.